Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clorazepate for Migraine Attack in the Emergency Room
NCT04726592Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clorazepate in migraine, sponsored by Assistance publique - Hôpitaux de Paris. Started Jul 2021; status: terminated.
02
Drugs
clorazepate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04726592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04726592.